MACCIONI, ANNA MARIA
 Distribuzione geografica
Continente #
EU - Europa 133.111
NA - Nord America 5.972
AS - Asia 2.619
SA - Sud America 308
AF - Africa 45
OC - Oceania 6
Totale 142.061
Nazione #
IT - Italia 130.981
US - Stati Uniti d'America 5.864
CN - Cina 1.059
SG - Singapore 917
UA - Ucraina 563
SE - Svezia 411
DE - Germania 349
BR - Brasile 247
FI - Finlandia 186
FR - Francia 185
GB - Regno Unito 184
VN - Vietnam 151
IN - India 98
NL - Olanda 87
HK - Hong Kong 84
KR - Corea 75
CA - Canada 54
BD - Bangladesh 45
PL - Polonia 28
IR - Iran 25
JP - Giappone 21
AR - Argentina 20
RU - Federazione Russa 20
BE - Belgio 19
PK - Pakistan 18
ES - Italia 17
MX - Messico 17
TR - Turchia 17
IQ - Iraq 16
VG - Isole Vergini Britanniche 16
CO - Colombia 15
SA - Arabia Saudita 14
ID - Indonesia 12
AT - Austria 11
CH - Svizzera 11
TW - Taiwan 11
IL - Israele 10
MA - Marocco 10
EC - Ecuador 9
PT - Portogallo 9
UZ - Uzbekistan 9
ZA - Sudafrica 9
AU - Australia 6
CL - Cile 6
DK - Danimarca 6
JM - Giamaica 6
PH - Filippine 6
TH - Thailandia 6
CZ - Repubblica Ceca 5
KE - Kenya 5
TN - Tunisia 5
UY - Uruguay 5
EG - Egitto 4
IE - Irlanda 4
LT - Lituania 4
RO - Romania 4
VE - Venezuela 4
AL - Albania 3
BG - Bulgaria 3
DZ - Algeria 3
GR - Grecia 3
HU - Ungheria 3
LU - Lussemburgo 3
MU - Mauritius 3
OM - Oman 3
RS - Serbia 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
GT - Guatemala 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
AZ - Azerbaigian 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
GE - Georgia 1
HN - Honduras 1
IS - Islanda 1
KW - Kuwait 1
MD - Moldavia 1
MM - Myanmar 1
MW - Malawi 1
PE - Perù 1
PR - Porto Rico 1
PY - Paraguay 1
SC - Seychelles 1
Totale 142.059
Città #
Cagliari 127.097
Uta 1.954
Chandler 507
Singapore 500
Ashburn 479
Fairfield 393
San Jose 393
Woodbridge 359
Jacksonville 310
Ann Arbor 303
Houston 297
Nyköping 287
Boardman 277
Beijing 243
Dallas 236
Wilmington 181
Seattle 145
Dearborn 140
Cambridge 130
Milan 119
Los Angeles 112
Helsinki 101
Hefei 100
Nanjing 96
Santa Clara 92
Boston 76
Rome 75
Hong Kong 74
Lauterbourg 69
Seoul 69
Shanghai 66
Naples 52
Buffalo 48
Ho Chi Minh City 47
Redwood City 46
Shenyang 40
Council Bluffs 39
The Dalles 39
New York 34
Guangzhou 33
Hanoi 28
Toronto 27
Verona 27
Frankfurt am Main 26
Mountain View 26
Hebei 25
Padova 25
Bari 24
Bologna 24
Changsha 24
Florence 24
Munich 24
Catania 23
Orem 23
Nanchang 22
Chennai 21
Chicago 21
São Paulo 21
Jiaxing 20
Tianjin 20
Jinan 19
Sassari 19
Turin 18
Brussels 17
Nürnberg 17
Road Town 16
Salerno 15
Parma 13
Tokyo 13
Brooklyn 12
Dong Ket 12
London 12
Norwalk 12
Nuremberg 12
Orange 12
Pisa 12
Rio de Janeiro 12
San Diego 12
Augusta 11
Pavia 11
Pune 11
Redondo Beach 11
Stockholm 11
Warsaw 11
Atlanta 10
Montreal 10
Ningbo 10
Palermo 10
Perugia 10
Phoenix 10
Lodz 9
Marigliano 9
Auburn Hills 8
Denver 8
Goiânia 8
Manchester 8
Mumbai 8
Rende 8
Saint Petersburg 8
Siena 8
Totale 136.596
Nome #
Formulation and characterization studies of trimethyl chitosan / sodium alginate nanoparticles for targeted drug delivery 4.606
From nanoemulsions to nanostructured lipid carriers: A relevant development in dermal delivery of drugs and cosmetics 4.160
Development of novel diolein-niosomes for cutaneous delivery of tretinoin: Influence of formulation and in vitro assessment 3.838
Phycocyanin-encapsulating hyalurosomes as carrier for skin delivery and protection from oxidative stress damage 3.643
Preparazione di nanoparticelle di TMC per il rilascio di farmaci a livello oculare 3.533
Preparation and characterization of TMC nanoparticles for colon specific drug delivery 3.502
Glycerosomes: use of hydrogenated soy phosphatidylcholine mixture and its effect on vesicle features and diclofenac skin penetration 3.494
Sintesi e caratterizzazione chimico-fisica di un derivato del chitosano per la realizzazione di sistemi nanoparticellari 3.474
Synthesis And Characterization Of A Chitosan Derivative For The Preparation Of Nanoparticles 3.285
PREPARATION OF TMC NANOPARTICLES FOR OCULAR DELIVERY 3.265
Physico-chemical characterization of succinyl chitosan-stabilized liposomes for the oral co-delivery of quercetin and resveratrol 3.021
Cavitation effect on chitosan nanoparticle size: A possible approach to protect drugs from ultrasonic stress 3.003
Glycerosomes: Investigation of role of 1,2-dimyristoyl-sn-glycero-3-phosphatidycholine (DMPC) on the assembling and skin delivery performances 3.000
Trimethyl chitosan hydrogel nanoparticles for progesterone delivery in neurodegenerative disorders 2.978
Potential therapeutic effect of curcumin loaded hyalurosomes against inflammatory and oxidative processes involved in the pathogenesis of rheumatoid arthritis: The use of fibroblast-like synovial cells cultured in synovial fluid 2.914
NANOPARTICELLE A BASE DI TMC E SA PER LA VEICOLAZIONE NOSE TO BRAIN 2.826
SINTESI DI TMC A DIVERSO GRADO DI QUATERNIZZAZIONE PER LA REALIZZAZIONE DI SISTEMI NANOPARTICELLARI 2.804
null 2.749
Composition influence on pulmonary delivery of rifampicin liposomes 2.722
PREPARAZIONE E CARATTERIZZAZIONE DI SISTEMI NANOPARTICELLARI DI TMC PER LA VEICOLAZIONE DI UN AGENTE ANTINFIAMMATORIO FITOTERAPICO MIRATO AL COLON 2.623
Preparazione e caratterizzazione di formulazioni cosmetiche contenenti olio di Neem 2.389
Nanoparticelle per la veicolazione nasale del Progesterone per il trattamento della malattia di Alzheimer 2.353
SYNTHESIS AND CHARACTERIZATION OF A CHITOSAN DERIVATIVE FOR THE PREPARATION OF NANOPARTICLES 2.318
Preparation and Characterization of TMC/SA nanoparticles for nose to brain drug delivery 2.296
BEADS DI CHITOSANO E SODIO ALGINATO: CARATTERISTICHE E PROPRIETÀ DI RILASCIO DI UN AGENTE FITOTERAPICO ANTINFIAMMATORIO 2.223
null 2.150
Approcci formulativi per ottimizzare l’incapsulazione nanoparticellare della Curcumina 2.149
SYNTHESIS OF COUMARIN -3-O-ACYLISOUREAS BY DICYCLOHEXYL CARBODIIMIDE 1.802
LIPOSOMI INCAPSULANTI E.S. DI UVA URSINA IN FORMULAZIONI COSMETICHE 1.749
null 1.580
null 1.507
null 1.415
Preservative systems containing essential oils in cosmetic products 1.399
Niosomi di triton CG 110 come carriers per l?8-metossipsoralene nelle patologie della pelle 1.372
Attività antivirale di liposomi contenenti l'olio essenziale di Santolina Insularis estratto con CO2 supercritica e in corrente di vapore 1.368
Cavitation Effect on Mean Diameter and Polydispersity Index of Chitosan Nanoparticles 1.299
Influence of polymeric system properties on the delivery of a phytoterapic anti-inflammatory agent 1.270
null 1.267
Stability studies of new cosmetic formulations with vegetable extracts as functional agents 1.260
Sistemi polimerici veicolanti l’estratto di Boswellia Serrata 1.181
Liposome loaded herbal extracts to enhance skin-whitening activity 1.171
Triton CG110 niosomes as carriers for the 8-methoxypsoralen in skin pathologies 1.157
Preparazione di nanoparticelle TMC/Alginato per la veicolazione al SNC 1.157
Chitosan beads loaded with essential oils in cosmetic formulations 1.134
Chitosan-beads loaded with Boswellia Serrata extract as phytoterapic anti-inflammatory agent 1.110
Physico-chemical stability of multilamellar liposomes entrapping caffeine 1.078
Chitosan and Protasan® Polymeric dispersions: Physical properties and effect on microparticle size 1.075
Phytotherapic anti-inflammatory agent delivery polymeric systems 1.006
Physical properties of chitosan dispersions in glycolic acid 992
null 987
Niosomi per la protezione degli agenti fotolabili 953
Studio di parametri fisici che intervengono nella realizzazione delle microsfere 944
Interfacial Phenomena Study in the Microspheres Production 935
Influence of rheological behaviour of polymeric matrices on the microsphere properties 924
Microparticles able to interfere on specific molecular targets involved in vascular proliferative diseases 886
Beads di chitosano incorporanti olii essenziali in formulazioni cosmetiche 886
Determinazione via GC/MS di bezafibrato, simvastatina e deidroepiandrosterone in sieri di ratti trattati con nitrato di piombo 879
Influenza dell'inclusione liposomiale sull'attività in vitro di miconazolo e ketoconazolo 869
MACROCYCLIC POLYETHER-DIESTER COMPOUNDS AS PHASE-TRANSFER CATALYSTS 861
Niosomi di triton CG110 per la veicolazione del 8-metossipsoralene 842
Preparazione di microsfere incapsulanti bezafibrato in grado di agire sul metabolismo lipidico 836
Phyisico-chemical stability of multilamellar liposomes entrapping caffeine 815
A CONVENIENT METHOD FOR THE SYNTHESIS OF MACROCYCLIC TETRAESTER COMPOUNDS. 814
Effetti dei liposomi sull'attività in vitro di alcuni antifungini 811
Assessment of the preserving activity of some essential oils in cosmetic products 806
Vescicole fosfolipidiche quali carriers per l’alimentazione in acquacoltura 788
?In vitro? release of liposomal caffeine: effects of polysorbates 767
STUDIES ON THE SYNTHESIS OF HETEROCYCLIC COMPOUNDS. XIII. THE SYNTHESIS OF MACROCYCLIC TETRAESTERS FROM 1,2-CYCLOHEXANE- AND 2,3-BUTANEDIOLS 755
STUDIES ON THE SYNTHESIS OF HETEROCYCLIC COMPOUNDS. XVI. CLEAVAGE OF 1,3-BENZODIOXOLES AND -BENZOXATHIOLES BY SODIUM IODIDE-ACYL CHLORIDE 750
null 739
null 733
null 724
MASS SPECTROMETRY AND CHEMICAL SYNTHESIS. THE CASE OF SOME SUBSTITUTED SPIRO [1,3-BENZODIOXOLE-2, 1′‐CYCLOHEXANES] 708
CHANGES IN THE LIPOPROTEIN PATTERN IN G-6-PD DEFICIENT CHILDREN DURING HAEMOLYTIC CRISIS 697
Rilascio di caffeina da strutture vescicolari 695
null 689
null 675
Studies on the synthesis of heterocyclic compounds. XIV. Cleavage of 1,3‐benzoxathioles by magnesium bromide‐acetic anhydride 674
null 623
MICONAZOLE, KETOCONAZOLE AND LIPOSOMAL PREPARATIONS: A REVERSED-PHASE HPLC DETERMINATION 621
SYNTHESIS AND PHARMACOLOGICAL PROPERTIES OF SOME AMIDES AND ESTERS OF 2,2-DIALKYL-1.3-BENZODIOXOLE-5--KETOBUTYRIC ACID 619
Studi di stabilità di formulazioni cosmetiche funzionalizzate con estratti vegetali 615
null 607
null 605
STUDIES ON THE SYNTHESIS OF HETEROCYCLIC COMPOUNDS. XVII. THE PREPARATION OF MACROCYCLIC POLYESTER LIGANDS CONTAINING THE 2,2'-BIS(HYDROXYMETHYL)DIPHENYLMETHANE SUBCYCLIC UNIT 593
null 586
Comparitive study of dissolution profiles in commercially available Aspirin tablets 566
Assessment of the preserving activity of some essential oils in cosmetic products 543
Evaporation-freezing behaviour of chitosan dispersions in glycolic acid 539
The role of Labrasol® in the enhancement of the cutaneous bioavailability of minoxidil in phospholipid Vesicles 504
null 489
Effetti della cavitazione ultrasonica sulle dimensioni e sulla distribuzione dimensionale di nanoparticelle 483
Formulazioni cosmetiche contenenti beads incapsulanti olio di Rosa mosqueta 356
Miconazole and ketoconazole in phospholipid formulations: in vitro antifungal activity 300
Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations 282
Niosomi di Triton CG110 come carriers per l’8-metossipsoralene nelle patologie della pelle 234
Totale 142.274
Categoria #
all - tutte 171.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 171.546


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.493 0 0 0 0 0 0 0 0 0 0 0 1.493
2021/20225.378 695 622 227 373 434 386 237 323 456 503 514 608
2022/20237.852 665 966 979 721 554 627 409 809 443 676 692 311
2023/202411.802 422 1.454 638 1.238 1.195 1.801 1.246 703 682 527 952 944
2024/202512.490 1.891 2.911 2.303 1.597 865 844 1.167 109 182 167 209 245
2025/20265.304 340 202 492 319 320 475 691 387 338 1.014 368 358
Totale 142.274